skip to Main Content
Loading...

2023 | Topic: Liver tumours Metabolism, alcohol and toxicity

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

Geneva, 18 April 2023This EASL Policy Statement about risk-based surveillance for hepatocellular carcinoma (HCC) among patients with cirrhosis demonstrates how risk-based surveillance has the potential to reduce not only deaths from HCC but also the costs of offering HCC surveillance.

 

Back To Top